ClinicalTrials.Veeva

Menu

Persistent Platelet Reactivity in Acute Coronary Syndrome

H

Hopital Lariboisière

Status

Completed

Conditions

Acute Coronary Syndrome

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Study of persistent platelet reactivity during acute coronary syndrome. Patients are included at admission to the hospital. Platelet aggregation is evaluated by platelet function testing after blood sampling during hospitalization. No changes in treatment is planned.

Full description

Blood samples are performed on day 2 and 4 and collected with usual blood samples and analyzed by the laboratory. Maximal aggregation intensity and velocity are measured by light transmission aggregometry induced by arachidonic acid (AA) or adenosine diphosphate (ADP). Platelet function analyzer will be also used. No changes in treatment in response to the results is planned.

Enrollment

106 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute coronary syndrome with elevation in troponin

Exclusion criteria

  • anticoagulant treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems